Andre Terzic News Today

Rion, founded in Rochester in 2017, plans to build a new manufacturing facility in a 10,000-square-foot space in Building 103 on the Rochester Technology Campus by the end of 2024 or early in 2025.

Stem cell-based therapy improved quality of life for patients with advanced heart failure, Mayo Clinic researchers and international collaborators discovered in a late-stage multinational clinical trial.

Investigators also found that the results demonstrated lower death and hospitalization rates for those with advanced heart failure treated with cell therapy.

Stem cell-based therapy improved quality of life for patients with advanced heart failure, Mayo Clinic researchers and international collaborators discovered in a late-stage multinational clinical trial.

Study documented lower death and hospitalization rates among those treated with cell therapy.

<p>Stem cell-based therapy improved quality of life for patients with advanced <a href="https://www.mayoclinic.org/diseases-conditions/heart-failure/symptoms-causes/syc-20373142" target="_blank">heart failure</a>, <a href="https://www.mayoclinic.org/" target="_blank">Mayo Clinic</a> researchers and international collaborators discovered in a late-stage multinational clinical trial.</p>

U.S. life expectancy rose slightly in 2022. But some experts say healthspan is a better longevity metric than lifespan.

Rochester-based Rion and Mayo Clinic recently won a $2.4 million U.S. Department of Defense grant to develop treatments for soldiers and veterans exposed to “airborne hazards in war zones.”

Rion, founded in 2017 by Mayo Clinic Drs. Andre Terzic and Atta Behfar with Scott Rosenow, is working with Rochester Area Economic Development, Inc., the city and the state to finance more space.

French Ambassador to the U.S. Philippe Étienne toured Mayo Clinic on Friday with U.S. Sen. Amy Klobuchar and local leaders as part of discussions about future scientific and economic collaborations.